Kornelia Polyak, MD, PhD

Kornelia PolyakKornelia Polyak, MD, PhD

Conference Cochair

Dana Farber Cancer Institut

Boston, MA, USA

Dr. Kornelia Polyakis a Professor of Medicine at Dana-Farber Cancer Institute, Harvard Medical School and is an internationally recognized leader of the breast cancer field. Dr. Polyak’s laboratory is dedicated to the molecular analysis of human breast cancer with the goal of improving the clinical management of breast cancer patients. Her lab has devoted much effort to develop new ways to study tumors and to apply interdisciplinary approaches. Using these methods Dr. Polyak’s lab has been at the forefront of studies analyzing defined cell populations from breast tissues at genomic scale and in situ at single cell level and to apply mathematical and ecological models for the better understanding of tumor evolution. She has also been successful with the clinical translation of her findings including the testing of efficacy of JAK and BET bromodomain inhibitors in clinical trials. Dr. Polyak has received numerous awards including the Paul Marks Prize for Cancer Research in 2011, the 2012 AACR Outstanding Investigator Award for Breast Cancer Research, and the Rosalind Franklin Award from NCI in 2016. She is also a 2015 recipient of the NCI Outstanding Investigator award. Dr. Polyak served as chair of the AACR Annual Meeting 2017.